Ordering Recommendation

Monitor HBV therapy; order along with HBV DNA, HBV surface antigen, HBV surface antibody, and HBe antigen.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Serum separator tube (SST). Also acceptable: Lavender (EDTA) or green (lithium heparin).

Specimen Preparation

Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP standard transport tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens that are heat-inactivated, grossly hemolyzed, grossly icteric, grossly lipemic specimens, or specimens containing particulate material.

Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 30 days (avoid repeated freeze/thaw cycles)

Methodology

Qualitative Chemiluminescent Immunoassay (CLIA)

Performed

Sun-Sat

Reported

Within 24 hours

Reference Interval

Negative

Interpretive Data

This assay should not be used for blood donor screening, associated reentry protocols, or for screening human cell, tissues, and cellular- and tissue-based products (HCT/P).

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

86707

Components

Component Test Code* Component Chart Name LOINC
0020095 Hepatitis Be Antibody 13953-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Chronic Hepatitis Profile
  • Chronic Hepatitis, HBeV
  • Hepatitis Be Ab, Antibody to Hepatitis Be antigen
  • Hepatitis Be Antibody
  • Hepatitis Be Antigen and Hepatitis Be Antibody, Serum
Hepatitis Be Virus Antibody